Loading…
Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico studies on ibuprofen derivatives
Novel ibuprofen derivatives 1 – 19 including ibuprofen hydrazide 1 , and substituted thiourea derivatives 2 – 19 were synthesized and characterized by EI-MS, FAB-MS, HREI-MS, HRFAB-MS, 1 H-, and 13 C-NMR spectroscopic techniques. The synthetic molecules 1 – 19 were examined for their in vitro urease...
Saved in:
Published in: | Molecular diversity 2021-02, Vol.25 (1), p.143-157 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Novel ibuprofen derivatives
1
–
19
including ibuprofen hydrazide
1
, and substituted thiourea derivatives
2
–
19
were synthesized and characterized by EI-MS, FAB-MS, HREI-MS, HRFAB-MS,
1
H-, and
13
C-NMR spectroscopic techniques. The synthetic molecules
1
–
19
were examined for their in vitro urease inhibition and were found to display a diversified degree of inhibitory potential in the range of IC
50
= 2.96–178 μM as compared to the standard thiourea (IC
50
= 21.32 ± 0.22 μM). Out of nineteen, thirteen derivatives
2
–
4
,
6
,
7
,
9
,
11
–
15
,
17
, and
18
demonstrated remarkable inhibitory activity with IC
50
values of 2.96 ± 1.11 to 16.1 ± 1.07 μM, compound
5
exhibited moderate inhibition with IC
50
value of 37.3 ± 0.41 μM, whereas, compounds
1
,
8
, and
10
demonstrated weak inhibition against urease enzyme. Almost all structural features are participating in the activity; however, limited structure–activity relationship was discussed on the basis of different structural features, i.e., different functional groups and their positions at aryl part. In addition, molecular docking study was performed in order to understand the ligands binding interactions with the active site of urease enzyme.
Graphic abstract |
---|---|
ISSN: | 1381-1991 1573-501X |
DOI: | 10.1007/s11030-019-10032-x |